Drugs with this side effect as MedDRA Preferred Term
- 1,25(OH)2D3
- 5-ASA
- 5-FU
- 5-aminolevulinic acid
- 5-aza-2'-deoxycytidine
- 5-azacytidine
- 5-fluorocytosine
- AMD3100
- BCNU
- BPTI
- Bivalirudin
- Haemorrhage: postmarketing, 0.0001% - 28%
- D-penicillamine
- Eptifibatide
- Haemorrhage: postmarketing, 0.02% - 19%
- FAMP
- FdUrd
- Fe(III
- Haemorrhage: postmarketing
- Forteo
- Glat copolymer
- Haemorrhage: postmarketing
- Goserelin
- ICI 182,780
- Haemorrhage: postmarketing
- Implanon
- Insulin
- K779
- LMWH
- Leuprorelin
- Meropenem anhydrous
- Metrodin
- MnDPDP
- NTBC
- Optison
- PCI-32765
- PGE1
- Haemorrhage: 1.6% - 14.8%
- Photofrin
- Photofrin II
- Refludan
- Haemorrhage: 0.7% - 21.5%
- Revasc
- Haemorrhage: postmarketing, 2.03% - 33%
- SOM230
- SU5416
- Stalevo 50
- Timentin
- UDCA
- Vitrum
- acamprosate
- acenocoumarol
- acetaminophen
- acitretin
- Haemorrhage: postmarketing
- alendronate
- allopurinol
- alosetron
- ambrisentan
- amiloride
- amlodipine
- amoxicillin
- amphotericin B
- amsacrine
- anagrelide
- anastrozole
- apixaban
- Haemorrhage: common, 1.13% - 1.37%
- argatroban
- aripiprazole
- arsenic
- arsenic trioxide
- articaine
- aspirin
- axitinib
- azathioprine
- aztreonam
- benzathine penicillin
- bexarotene
- bicalutamide
- bleomycin hydrochloride
- bortezomib
- bosentan
- budesonide
- bupropion
- buspirone
- busulfan
- cabozantinib
- caffeine
- candesartan
- candesartan cilexetil
- capecitabine
- carbimazole
- carboplatin
- carnitine
- carvedilol
- cefaclor
- cefadroxil
- cefazolin
- cefdinir
- Haemorrhage: postmarketing
- cefditoren
- cefepime
- Haemorrhage: postmarketing
- cefixime
- Haemorrhage: postmarketing
- cefotaxime
- Haemorrhage: postmarketing
- cefotetan
- cefoxitin
- cefpodoxime
- Haemorrhage: postmarketing
- cefprozil
- ceftazidime
- Haemorrhage: postmarketing
- ceftizoxime
- ceftriaxone
- Haemorrhage: postmarketing
- cefuroxime
- Haemorrhage: postmarketing
- cefuroxime axetil
- celecoxib
- cephalexin
- cephem
- Haemorrhage: postmarketing
- cevimeline
- ciclesonide
- cilostazol
- ciprofloxacin
- Haemorrhage: postmarketing
- citalopram
- cladribine
- clarithromycin
- Haemorrhage: postmarketing
- clofarabine
- clonazepam
- clopidogrel
- Haemorrhage: very rare, postmarketing, uncommon, 0.001% - 8.5%
- clotrimazole
- colestyramine
- copolymer 1
- Haemorrhage: postmarketing
- copper
- Haemorrhage: 2.2% - 11.9%
- cortisol
- cortisone
- cosyntropin
- cyclophosphamide
- cyproterone acetate
- cytarabine
- cytokinin
- dabigatran
- Haemorrhage: 0.292% - 26.2%
- dabigatran etexilate
- dabrafenib
- dalteparin
- danazol
- dantrolene
- darunavir
- dasatinib
- deferasirox
- demethyl
- desflurane
- Haemorrhage: postmarketing
- dexamethasone
- dexamethasone sodium phosphate
- dexmedetomidine
- Haemorrhage: postmarketing, 3%
- dexrazoxane
- diatrizoate
- diazoxide
- diclofenac
- dipyridamole
- docetaxel
- Haemorrhage: postmarketing, rare
- donepezil
- doxorubicin
- Haemorrhage: postmarketing
- drospirenone (DRSP
- duloxetine
- Haemorrhage: very rare, postmarketing
- entacapone
- epinephrine
- erlotinib
- ertapenem
- eslicarbazepine acetate
- estradiol
- Haemorrhage: postmarketing
- etodolac
- etoricoxib
- Haemorrhage: postmarketing
- everolimus
- exemestane
- exenatide
- Haemorrhage: postmarketing
- felbamate
- fenoldopam
- fenoprofen
- fentanyl
- ferumoxytol
- Haemorrhage: postmarketing
- fludarabine
- fludrocortisone
- fludrocortisone acetate
- fluoxetine
- Haemorrhage: infrequent, common, frequent
- fluoxymesterone
- flurbiprofen
- fluticasone
- Haemorrhage: postmarketing
- fluvoxamine
- Haemorrhage: postmarketing, rare
- fondaparinux
- Haemorrhage: postmarketing, uncommon, common, 0% - 5.02%
- fosamprenavir
- fosinopril
- frovatriptan
- gadoversetamide
- galantamine
- Haemorrhage: rare, infrequent
- ganciclovir
- gefitinib
- gemcitabine
- gemifloxacin
- Haemorrhage: postmarketing
- heparin
- Haemorrhage: postmarketing
- hepatitis B vaccines
- hetastarch
- Haemorrhage: postmarketing
- hydroxychloroquine
- hydroxyurea
- ibandronate
- ibuprofen
- Haemorrhage: 4.28% - 9.7%
- icodextrin
- idarubicin
- ifosfamide
- iloprost
- Haemorrhage: postmarketing
- imatinib
- Haemorrhage: postmarketing, common, 0% - 53%
- imiquimod
- indinavir
- Haemorrhage: postmarketing
- indomethacin
- insulin detemir
- iodide
- iopamidol
- iopromide
- iotrolan
- ioversol
- ioxaglate
- ipratropium bromide
- irinotecan
- Haemorrhage: postmarketing, 1% - 5%
- isomannide
- isosorbide-5-mononitrate
- ixabepilone
- ketorolac
- Haemorrhage: postmarketing
- ketorolac tromethamine
- lamotrigine
- Haemorrhage: rare, 2% - 3%
- lasofoxifene
- leflunomide
- lenalidomide
- letrozole
- levonorgestrel
- lidocaine
- linezolid
- lomustine
- mTHPC
- mafenide acetate
- meclofenamate
- medroxyprogesterone
- Haemorrhage: postmarketing, 8.2%
- medroxyprogesterone acetate
- Haemorrhage: postmarketing
- mefenamic acid
- meloxicam
- melphalan
- memantine
- meropenem
- methotrexate
- methylphenidate
- Haemorrhage: postmarketing
- methylprednisolone
- methyltestosterone
- mifepristone
- miglustat
- mitoxantrone
- mometasone furoate
- moxifloxacin
- mupirocin
- mycophenolate mofetil
- mycophenolic acid
- nabumetone
- nandrolone
- naproxen
- naratriptan
- nefazodone
- nelfinavir
- niacin
- nifedipine
- nilotinib
- nitric oxide
- nitrogen mustard
- norethisterone
- ofloxacin
- Haemorrhage: postmarketing
- olanzapine
- ondansetron
- orlistat
- oxaliplatin
- Haemorrhage: postmarketing
- oxandrolone
- oxaprozin
- oxycodone
- oxymetholone
- paclitaxel
- Haemorrhage: very common, 2% - 14%
- pamidronate
- pantoprazole
- paroxetine
- pazopanib
- penicillin
- pentostatin
- pentoxifylline
- perindopril erbumine
- phenytoin
- piperacillin
- piroxicam
- podophyllotoxin
- Haemorrhage: 0.7% - 19.2%
- ponatinib
- posaconazole
- potassium
- pralidoxime
- prasugrel
- Haemorrhage: 0.5% - 14.1%
- prednisolone
- prednisolone acetate
- prednisolone phosphate
- prednisone
- pregabalin
- procarbazine
- progesterone
- propafenone
- proparacaine
- propofol
- propylthiouracil
- prostacyclin
- quetiapine
- quinidine
- rapamycin
- rasagiline
- regorafenib
- remifentanil
- retinoic acid
- Haemorrhage: postmarketing, common, 60%
- ribavirin
- rifaximin
- riluzole
- riociguat
- risedronate
- risperidone
- ritonavir
- Haemorrhage: postmarketing
- rivaroxaban
- rivastigmine
- ropinirole
- ruxolitinib
- Haemorrhage: very common, 2.3% - 32.6%
- salbutamol
- Haemorrhage: postmarketing
- salsalate
- samarium
- saquinavir
- Haemorrhage: postmarketing
- sertraline
- sevoflurane
- sibutramine
- sildenafil
- Haemorrhage: postmarketing
- sitaxsentan
- sodium ferric gluconate
- sorafenib
- Haemorrhage: postmarketing, very common, 0% - 15%
- sotalol
- sparfloxacin
- sumatriptan
- sunitinib
- Haemorrhage: postmarketing, 2%
- suprofen
- tacrolimus
- Haemorrhage: uncommon, common
- tadalafil
- tamoxifen
- tazarotene
- temozolomide
- Haemorrhage: common, 1% - 9%
- teniposide
- tesamorelin
- testosterone
- testosterone enanthate
- testosterone propionate
- testosterone undecanoate
- thiamine
- thiotepa
- tiagabine
- tiaprofenic acid
- ticagrelor
- Haemorrhage: 0.0246% - 7.9%
- ticlopidine
- tiopronin
- tipranavir
- tirofiban
- tizanidine
- tolcapone
- topiramate
- topotecan
- Haemorrhage: postmarketing, common, 1% - 14%
- torasemide
- trabectedin
- tramadol
- trametinib
- tranexamic acid
- Haemorrhage: postmarketing
- trans 4-cyclohexyl-L-proline
- tranylcypromine
- treprostinil
- triamcinolone
- triamcinolone acetonide
- trimethadione
- trovafloxacin
- ustekinumab
- v 1784
- Haemorrhage: postmarketing
- valdecoxib
- valganciclovir
- valproate
- valsartan
- vandetanib
- vardenafil
- venlafaxine
- Haemorrhage: postmarketing, rare, infrequent, uncommon, common
- verteporfin
- vinblastine
- vorapaxar
- warfarin
- zafirlukast
- zanamivir
- ziprasidone
|
